Podcast thumbnail for Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

Claim This Podcast

by Lynn Marie Morski, MD, JD

4.9(226 reviews)
204 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
67

Podcast Authority

Beta
GoodBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality96
Social0
YouTube0
Engagement96

Podcast Overview

Curious about the possible therapeutic benefits of psychedelic medicines? The Psychedelic Medicine Podcast with Dr. Lynn Marie Morski has you covered with the latest in scientific research, medical practices, and legal developments involving these substances and their incredible therapeutic potential. Covering the full range of psychedelic therapies, including psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and more, this podcast serves as an auditory encyclopedia of information for anyone interested in learning about the safe, therapeutic uses of these medicines.

Language

🇺🇲

Publishing Since

8/9/2019

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

67

Podcast Authority

Beta
GoodBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality96
Social0
YouTube0
Engagement96
8
Excellent Areas
3
Good Performance
8
Growth Opportunities
excellent
Episode Length
38 minutes
Performing excellently!
good
Publishing Consistency
Every 12 days

Recommendations available

Unlock the full report to see detailed tips

poor
Episode Thumbnails

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

1 verified contact email on file for Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for Psilocybin vs. Ketamine with Dori Lewis, LPC

July 2, 2026

Psilocybin vs. Ketamine with Dori Lewis, LPC

Dr. Lynn Marie Morski interviews Dori Lewis, LPC, exploring how to choose between psilocybin and ketamine for therapeutic benefits.

Episode thumbnail for Choosing the Right Ketamine Clinic for You with Katie Fassbinder, MD

June 11, 2026

Choosing the Right Ketamine Clinic for You with Katie Fassbinder, MD

Dr. Lynn Marie Morski interviews Dr. Katie Fassbinder on choosing the right ketamine clinic by prioritizing safety, support, and personal fit for effective treatment.

Episode thumbnail for The Future of Psychedelic Medicine with Ismail Lourido Ali, JD

May 14, 2026

The Future of Psychedelic Medicine with Ismail Lourido Ali, JD

<p dir="ltr">In the 200th episode of the Psychedelic Medicine Podcast, Ismail Lourido Ali, JD joins to discuss the future of psychedelic medicine. Ismail serves as MAPS Co-Executive Director and has been actively participating in the drug policy reform movement for over a decade, informed by half a lifetime of diverse personal experience with psychedelics and other substances.</p> <p dir="ltr">In this conversation, Ismail explores the rapidly evolving landscape of psychedelic medicine, reflecting on the field's major milestones, challenges, and future possibilities. He discusses how public perception has shifted over the past decade, the role of state-level psychedelic reforms, and the tensions created by commercialization, overhype, and competing regulatory models. Much of the discussion focuses on the recent federal executive order related to psychedelic research and drug development, including what it may mean for FDA approval timelines, right-to-try access, rescheduling, and public health standards. Throughout, Ismail emphasizes that psychedelics are not a "silver bullet," but tools that require strong systems of care, thoughtful policy, and community support to be integrated responsibly into healthcare and society.</p> <p><strong> </strong></p> <p dir="ltr"><strong>In this episode, you'll hear:</strong></p> <ul> <li dir="ltr">How public attitudes toward psychedelics have shifted over the past decade</li> <li dir="ltr">Major milestones that expanded psychedelic policy reform beyond federal drug approval</li> <li dir="ltr">The promises and pitfalls of increased visibility, commercialization, and hype in the psychedelic field</li> <li dir="ltr">What the recent federal executive order on psychedelics actually does and does not do</li> <li dir="ltr">An explanation of right-to-try laws, FDA approval pathways, and the complexities of rescheduling psychedelic medicines</li> <li dir="ltr">Why maintaining rigorous evidentiary standards is essential for the long-term credibility of psychedelic medicine</li> <li dir="ltr">MAPS' vision for the future of psychedelic access, including regulated adult use, professional education, and community safety infrastructure</li> <li dir="ltr">How psychedelic policy reform could evolve to include broader systems of mental health care, crisis response, and social healing</li> </ul> <p><strong> </strong></p> <p dir="ltr"><strong>Quotes:</strong></p> <p dir="ltr">"[Federal funding for psychedelic research] will only be so effective unless there is a massive reinvestment in mental health, harm reduction, and social services that actually ground—and one could say integrate—this medicine into like the continuum of care and the fabric of community that people are actually in." [25:07]</p> <p dir="ltr">"Even though those of us in the psychedelic advocacy field do want to see drugs like MDMA and others be approved by the FDA for medical use in these controlled clinical settings… At the same time, we don't want medical access to be accelerated so much that it's at the expense of public health or consumer protection or an evidentiary standard that other drugs are being held to." [37:59]</p> <p dir="ltr">"Medical professionals are not just prescribing things because they're approved. Many of them want to look at the evidence themselves. They want to look at the clinical trials. They want to understand 'is this the right choice for my patient?' But you can only know if [psychedelics] are being held to a comparable standard." [39:31]</p> <p dir="ltr">"What's MAPS' vision for ten years from now or 40 years from now for that matter? I like to think of it as lots of on ramps and lots of off ramps. It's that people who are seeking access to psychedelics for any beneficial purpose—for their own treatment or healing, for their own spiritual growth, for their personal development, for their for improving of their relationships with their loved ones or with nature or with spirituality, whatever that cosmology is that they hold—that they have safe, responsible methods of doing so." [44:47]</p> <p><strong> </strong></p> <p dir="ltr"><strong>Links:</strong></p> <p dir="ltr"><a href="https://www.instagram.com/sage_izzy">Ismail on Instagram</a></p> <p dir="ltr"><a href= "https://psychedelicmedicineassociation.org/">Psychedelic Medicine Association</a></p> <p dir="ltr"><a href="https://www.porangui.com/">Porangui</a></p>

204 total episodes available with 29 transcripts

Recent guests on Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Dori Lewis

Guest

Katie Fassbinder

Guest

Michelle Weiner

Guest

Dr Simon Ruffell

Guest

Hunt Priest MDiv

Guest

Manesh Girn PhD

Guest

Matthew Hicks ND MS

Guest

Rotem Petranker PhD

Guest

Rick Strassman MD

Guest

Steven Zeiler MD PhD

Guest

J Ashley T Booth LCSW MS

Guest

Dr Genesee Herzberg

Guest

Deep-dive analytics for Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Psychedelic Medicine Podcast with Dr. Lynn Marie Morski?

Curious about the possible therapeutic benefits of psychedelic medicines? The Psychedelic Medicine Podcast with Dr. Lynn Marie Morski has you covered with the latest in scientific research, medical practices, and legal developments involving these substances and their incredible therapeutic potential. Covering the full range of psychedelic therapies, including psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and more, this podcast serves as an auditory encyclopedia of information for anyone interested in learning about the safe, therapeutic uses of these medicines.

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.